Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients

Gene

Volumn 492, Issue 1, 2012, Pages 285-289

  Akpolat, Tekin ^a   Özkaya, Ozan ^a   Özen, Seza ^b  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Autoinflammatory diseases; MEFV

Indexed keywords

AMYLOIDOSIS; ARTICLE; AUTOIMMUNE DISEASE; DISEASE SEVERITY; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TURKEY (REPUBLIC);

AMYLOIDOSIS; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; HOMOZYGOTE; HUMANS; MUTATION; RISK FACTORS; TURKEY;

EID: 84155186412     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.10.012     Document Type: Article

References (49)

1. Akpolat T., et al. Ailevi Akdeniz ateşinde M694V ve amiloidoz ilişkisi: var mi yok mu [The relationship between M694V and amyloidosis in FMF: present or absent?] Turk. Neph. Dial. Transpl. 2010, 19(Suppl, 58). (Turkish).
2. Albayrak F. Genotype-phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey). Genet. Test. Mol. Biomarkers 2010, 14:325-328.
3. Anderson, et al. Structural, expression, and evolutionary analysis of mouse CIAS1. Gene 2004, 338:25-34.
4. Atagunduz M.P., et al. Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis. Nephron Clin. Pract. 2004, 96:131-135.
5. Cakar N., et al. Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome. Clin. Exp. Rheumatol. 2001, 19(Suppl24):S63-S67.
6. Cazeneuve C., et al. MEFV-gene analysis in Armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am. J. Hum. Genet. 1999, 65:88-97.
7. Chae J.J., et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9982-9987.
8. Delibaş A., et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am. J. Nephrol. 2005, 25:434-440.
9. Duşunsel R., et al. Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr. Int. 2008, 50:208-212.
10. Erdaǧ G.Ç., et al. Cases with familial Mediterranean fever. J. Kartal Training Res. Hospital 2008, 19:131-137.
11. Ertekin V., et al. Familial Mediterranean fever in a childhood population in eastern Turkey. Pediatr. Int. 2005, 47:640-644.
12. Gershoni-Baruch R., et al. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003, 48:1149-1155.
13. Inal A., et al. The clinical and genetical features of 124 children with Familial Mediterranean fever: experience of a single tertiary center. Rheumatol. Int. 2009, 29:1279-1285.
14. Kastner D.L., et al. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010, 140:784-790.
15. Koksal B., et al. Clinical and molecular analysis of common MEFV gene mutations in familial Mediterranean fever in Sivas population. Biologia 2009, 64:388-393.
16. Kluwe-Beckerman B., Song M. Genes encoding human serum amyloid A proteins SAA1 and SAA2 are located 18kb apart in opposite transcriptional orientations. Gene 1995, 159:289-290.
17. Livneh A., et al. The changing face of familial Mediterranean fever. Semin. Arthritis Rheum. 1996, 26:612-627.
18. Livneh A., et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997, 40:1879-1885.
19. Mansour I., et al. Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur. J. Hum. Genet. 2001, 9:51-55.
20. Medlej-Hashim M., et al. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. B.M.C. Med. Genet. 2004, 5:4.
21. Mimouni A., et al. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000, 105(5):E70.
22. Ozalkaya E., et al. Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey. Rheumatol. Int. 2011, 31:779-784.
23. Ozen S., et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J. Rheumatol. 1998, 25:2445-2449.
24. Ozen S., et al. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann. Rheum. Dis. 2009, 68:246-248.
25. Ozen S. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation?. Arthritis Rheum. 2009, 60:1575-1577.
26. Oztürk A., et al. Is MEFV gene Arg202Gln (605 G>A) a disease-causing mutation?. Turk. J. Med. Sci. 2008, 38:205-208.
27. Pasa S., et al. Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features. Amyloid. 2008, 15:49-53.
28. Peru H., et al. The evaluation of patients with familial Mediterranean fever in Konya region: a retrospective clinic and genetic study. Genel. Tip. Derg. 2008, 18:1-7.
29. Pras M., Sohar E. Familial Mediterranean fever. Rheumatology 1994, 3-4. Mosby, St. Louis. J.H. Klippel, P.A. Dieppe (Eds.).
30. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of pyrin gene. Scand. J. Rheumatol. 1998, 27:92-97.
31. Saatçi Ü., et al. Renal involvement in Turkish patients with familial Mediterranean fever (FMF). Clin. Exp. Rheumatol. 2002, 20(Suppl 26):89.
32. Sack G.H. Molecular cloning of human genes for serum amyloid A. Gene 1983, 21:19-24.
33. Samli H., et al. Relationship of Tel Hashomer criteria and Mediterranean fever gene mutations in a cohort of Turkish familial Mediterranean fever patients. Saudi Med. J. 2006, 27:1822-1826.
34. Sayhan N., et al. MEFV gene analysis in familial Mediterranean fever patients from Turkey: prognostic value of M694V homozygous phenotype. Clin. Exp. Rheum. 2000, 18:286.
35. Schwabe A.D., Peters R.S. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore) 1974, 53:453-462.
36. Shohat M., et al. Amyloidosis in familial mediterranean fever is associated with a specific ancestral haplotype in the MEFV locus. Mol. Genet. Metab. 1998, 65:197-202.
37. Shohat M., et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur. J. Hum. Genet. 1999, 7:287-292.
38. Solak M., et al. Analysis of familial Mediterranean fever gene mutations in 202 patients with familial Mediterranean fever. Genet. Test. 2008, 12:341-344.
39. Soylemezoglu O., et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J. Rheumatol. 2010, 37:182-189.
40. Touitou I., et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007, 56:1706-1712.
41. Tuglular S., et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol. Dial. Transplant. 2002, 17:2003-2005.
42. Tunca M., et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005, 84:1-11.
43. Turkcapar N., et al. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol. Int. 2007, 27:545-551.
44. Ureten K., et al. Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol. Int. 2010, 30:911-915.
45. Yalçinkaya F., et al. Familial Mediterranean fever-amyloidosis and the Val726Ala mutation. N. Engl. J. Med. 1998, 338:993-994.
46. Yalçinkaya F., et al. Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford) 2000, 39:67-72.
47. Yilmaz E., et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur. J. Hum. Genet. 2001, 9:553-555.
48. Yilmaz E., et al. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk. J. Pediatr. 2003, 45:198-202.
49. Yigit S., et al. MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience. J. Rheumatol. 2008, 35:106-113.